benzoxazoles has been researched along with Retinal Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Jeong, H; Kurihara, T; Lee, D; Miwa, Y; Negishi, K; Tomita, Y; Tsubota, K | 1 |
| Fujikawa, T; Sogabe, Y | 1 |
| Agarwal, N; Hara, H; Shimazawa, M; Yamashima, T | 1 |
3 other study(ies) available for benzoxazoles and Retinal Diseases
| Article | Year |
|---|---|
Pemafibrate Prevents Retinal Dysfunction in a Mouse Model of Unilateral Common Carotid Artery Occlusion.
Topics: Animals; Arterial Occlusive Diseases; Benzoxazoles; Butyrates; Carotid Artery, Common; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Retinal Diseases | 2021 |
Lipid Metabolic Disorder with Varied Clinical Manifestations.
Topics: Adult; Benzoxazoles; Blood Glucose; Butyrates; Diabetes Mellitus, Type 2; Diet, Fat-Restricted; Humans; Hyperlipidemias; Hypertriglyceridemia; Hypolipidemic Agents; Insulin; Lipid Metabolism Disorders; Male; Retinal Diseases; Xanthomatosis | 2022 |
Neuroprotective effects of minocycline against in vitro and in vivo retinal ganglion cell damage.
Topics: Animals; Benzimidazoles; Benzoxazoles; Cell Count; Cell Death; Cell Line; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Drug Interactions; Endoplasmic Reticulum; Excitatory Amino Acid Agonists; Fluorescent Dyes; Male; Mice; Minocycline; N-Methylaspartate; Neuroprotective Agents; Propidium; Quinolinium Compounds; Rats; Reactive Oxygen Species; Retina; Retinal Diseases; Retinal Ganglion Cells; Tunicamycin | 2005 |